
Arthroplasty
Combined Topical & IV TXA superior to topical TXA alone for reducing blood loss in TKA
J Arthroplasty. 2015 May;30(5):776-80One hundred and twenty patients with a diagnosis of primary osteoarthritis (OA) scheduled for unilateral total knee arthroplasty were randomized to receive either a combination of topical and intravenous administration of tranexamic acid, topical administration alone, or a saline control. Initial hemoglobin levels and postoperative drop, total drain amount, total blood loss, and transfusion rate were assessed 1 and 3 days postoperatively. Results indicated that the combined treatment and topical treatment alone both are viable treatment options compared to the control, with the combined group displaying potential as the superior treatment.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.